[1]
T. Sio, “Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors”, Radiol Oncol, vol. 54, no. 4, pp. 480–487, Nov. 2020.